3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Gastrointestinal
1
Conditions
Pancreatic Neoplasms
24
Colorectal Neoplasms
16
Small Cell Lung Carcinoma
6
Stomach Neoplasms
5
Neoplasms
4
Neoplasm Metastasis
4
Biliary Tract Neoplasms
4
Sarcoma, Ewing
3
Rhabdomyosarcoma
3
Recurrence
3
Rectal Neoplasms
3
Osteosarcoma
3
Ovarian Neoplasms
2
Nasopharyngeal Carcinoma
2
Glioma
2
Glioblastoma
2
Gastrointestinal Neoplasms
2
Fallopian Tube Neoplasms
2
Esophageal Neoplasms
2
Cholangiocarcinoma
2
Wilms Tumor
1
Weight Loss
1
Triple Negative Breast Neoplasms
1
Somatostatinoma
1
Solid Tumor Cancer
1
Solid Tumor
1
Small Cell Lung Cancer Extensive Stage
1
Small Bowel Adenocarcinoma
1
Sarcoma
1
Rhabdoid Tumor
1
Interventions
Mitomycin
9
Oxaliplatin
7
Hyperthermic Intraperitoneal Chemotherapy
7
Leucovorin
5
Irinotecan
5
Fluorouracil
4
Surveys and Questionnaires
3
Cisplatin
3
Capecitabine
3
dehydroftorafur
2
Thalidomide
2
Mitozytrex
2
Doxorubicin
2
Cytoreduction Surgical Procedures
2
Biopsy
2
surufatinib
1
sintilimab
1
nintedanib
1
irinotecan sucrosofate
1
durvalumab
1
Yoga
1
Watchful Waiting
1
Surgical Procedures, Operative
1
Specimen Handling
1
Referral and Consultation
1
Psychiatric Rehabilitation
1
Platinum
1
Pharmacogenomic Testing
1
Palonosetron
1
Pafolacianine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Appendiceal Neoplasms
×
irinotecan sucrosofate
×
Clear all
NCT05277766
2025-07-01
PIPAC-NAL-IRI
University Hospital, Ghent
Phase 1
Recruiting
45 enrolled